Results 11 to 20 of about 3,027 (171)

Enhancing Gpx1 Palmitoylation to Inhibit Angiogenesis by Targeting PPT1

open access: yesRedox Biology
The significance of protein S-palmitoylation in angiogenesis has been largely overlooked, leaving various aspects unexplored. Recent identification of Gpx1 as a palmitoylated protein has generated interest in exploring its potential involvement in novel ...
Shaobo Su, Azim Patar, Eryan Kong
exaly   +6 more sources

The Interactome of Palmitoyl-Protein Thioesterase 1 (PPT1) Affects Neuronal Morphology and Function [PDF]

open access: yesFrontiers in Cellular Neuroscience, 2019
Palmitoyl-protein thioesterase 1 (PPT1) is a depalmitoylation enzyme that is mutated in cases of neuronal ceroid lipofuscinosis (NCL). The hallmarks of the disease include progressive neurodegeneration and blindness, as well as seizures.
Orly Reiner   +2 more
exaly   +9 more sources

An over-expression system for characterizing Ppt1 function in Drosophila [PDF]

open access: yesBMC Neuroscience, 2003
Background The infantile onset form of Neuronal Ceroid Lipofuscinoses (INCL) is the earliest and most severe form of NCL, with neurological symptoms that reflect massive neurodegeneration in the CNS and retina.
Korey Christopher A   +3 more
core   +6 more sources

Quantitative analysis of PPT1 interactome in human neuroblastoma cells. [PDF]

open access: yesData in Brief, 2015
Mutations in the CLN1 gene that encodes Palmitoyl protein thioesterase 1 (PPT1) or CLN1, cause Infantile NCL (INCL, MIM#256730). PPT1 removes long fatty acid chains such as palmitate from modified cysteine residues of proteins. The data shown here result
Gingras, Anne-Claude   +14 more
core   +8 more sources

Intratumoral PPT1-positive macrophages determine immunosuppressive contexture and immunotherapy response in hepatocellular carcinoma

open access: yesJournal for ImmunoTherapy of Cancer, 2023
Background Hepatocellular carcinoma (HCC) is a malignancy with limited treatment options and poor prognosis. Macrophages are enriched in the HCC microenvironment and have a significant impact on disease progression and therapy efficacy.
Yong Yi   +11 more
core   +5 more sources

Seizures in PPT1 Knock-In Mice Are Associated With Inflammatory Activation of Microglia

open access: yesInternational Journal of Molecular Sciences, 2022
Infantile neuronal ceroid lipofuscinosis (INCL), the most severe form of neuronal ceroid lipofuscinoses, is caused by mutations in the lysosomal enzyme palmitoyl protein thioesterase 1 (PPT1).
Shiyong Peng, Mingyong Wang, Tong Jia
exaly   +4 more sources

High PPT1 expression predicts poor clinical outcome and PPT1 inhibitor DC661 enhances sorafenib sensitivity in hepatocellular carcinoma [PDF]

open access: yesCancer Cell International, 2021
Abstract Background Adaptive resistance and side effects of sorafenib treatment result in unsatisfied survival of patients with hepatocellular carcinoma (HCC). Palmitoyl-protein thioesterase 1 (PPT1) plays a critical role in progression of various cancers.
Jianjun Xu   +10 more
openaire   +3 more sources

PPT1 inhibition enhances the antitumor activity of anti–PD-1 antibody in melanoma [PDF]

open access: yesJCI Insight, 2020
New strategies are needed to enhance the efficacy of anti–programmed cell death protein antibody (anti–PD-1 Ab) in cancer. Here, we report that inhibiting palmitoyl-protein thioesterase 1 (PPT1), a target of chloroquine derivatives like ...
Jennifer J. Lee   +19 more
core   +5 more sources

PPT1 Promotes Tumor Growth and Is the Molecular Target of Chloroquine Derivatives in Cancer [PDF]

open access: yesCancer Discovery, 2019
Clinical trials repurposing lysosomotropic chloroquine (CQ) derivatives as autophagy inhibitors in cancer demonstrate encouraging results, but the underlying mechanism of action remains unknown.
Estela Noguera-Ortega   +2 more
exaly   +4 more sources

AAV-Delivered PPT1 Provides Long-Term Neurological Benefits in CLN1 Mice and Achieves Therapeutic Levels in Sheep Brain [PDF]

open access: yesMolecular Therapy
CLN1 disease is a fatal neurodegenerative condition caused by deficiency in Palmitoyl-Protein Thioesterase 1 (PPT1), for which no disease-modifying therapy exists.
Suhail Alam, Maria G Biferi
exaly   +4 more sources

Home - About - Disclaimer - Privacy